Literature DB >> 14978743

MEKK2 regulates the coordinate activation of ERK5 and JNK in response to FGF-2 in fibroblasts.

Kamala Kesavan1, Katherine Lobel-Rice, Weiyong Sun, Razvan Lapadat, Saiphone Webb, Gary L Johnson, Timothy P Garrington.   

Abstract

Mitogen-activated protein kinases (MAPKs) are regulated by MAPK kinases (MKKs), which are in turn regulated by MKK kinases (MKKKs). While a single MKKK can regulate several different MAPK family members, and several MKKKs can often activate the same MAPK, emerging evidence indicates a unique role for individual MKKKs in acting as signaling nodes to coordinately activate different subsets of MAPKs in response to specific cellular stimuli. Thus, while there is much apparent overlap in MAPK regulation by different MKKKs, each MKKK serves a specific purpose in regulation of unique cellular functions. The purpose of this study was to define the specific role of MEKK2, an MKKK, in MAPK regulation and cell function. MEKK2 coordinately activates the ERK5 and JNK pathways. Targeted disruption of MEKK2 expression causes loss of ERK5 and JNK activation in response to FGF-2 in mouse embryonic fibroblasts (MEFs). FGF-2 receptor signaling requires MEKK2 for induction of mRNA for c-Jun, Fra-1, and Fra-2, components of the AP-1 transcription complex. In FGF-2-stimulated MEKK2-/- fibroblasts, c-Jun phosphorylation is inhibited, consistent with a loss of JNK activation. Thus, MEKK2 regulates AP-1 activity at two levels, by regulating both expression of AP-1 components and c-Jun N-terminal phosphorylation. One function of the AP-1 transcription complex is to regulate cytokine gene expression. Expression of IL-1alpha, IL-1beta, IL-6, and TNFalpha is inhibited in MEKK2-/- fibroblasts. Bacterial lipopolysaccharide (LPS) and TNFalpha neither activate ERK5 nor require MEKK2 for JNK activation, demonstrating specificity of MEKK2 in FGF-2 receptor signaling and control of cytokine gene expression. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978743     DOI: 10.1002/jcp.10457

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  33 in total

1.  Metabolic stress signaling mediated by mixed-lineage kinases.

Authors:  Anja Jaeschke; Roger J Davis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

2.  Identification of MEKK2/3 serine phosphorylation site targeted by the Toll-like receptor and stress pathways.

Authors:  Dongyu Zhang; Valeria Facchinetti; Xiaofang Wang; Qiaojia Huang; Jun Qin; Bing Su
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

3.  Discovery and characterization of an iminocoumarin scaffold as an inhibitor of MEKK2 (MAP3K2).

Authors:  Syed Ahmad; Valentine R St Hilaire; Srinivasa R Dandepally; Gary L Johnson; Alfred L Williams; John E Scott
Journal:  Biochem Biophys Res Commun       Date:  2018-01-05       Impact factor: 3.575

Review 4.  Cell Signaling and Stress Responses.

Authors:  Gökhan S Hotamisligil; Roger J Davis
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-10-03       Impact factor: 10.005

5.  Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.

Authors:  Satoko Nishimoto; Morioh Kusakabe; Eisuke Nishida
Journal:  EMBO Rep       Date:  2005-09-23       Impact factor: 8.807

6.  PB1 domain-dependent signaling complex is required for extracellular signal-regulated kinase 5 activation.

Authors:  Kazuhiro Nakamura; Mark T Uhlik; Nancy L Johnson; Klaus M Hahn; Gary L Johnson
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

7.  CHIP-dependent termination of MEKK2 regulates temporal ERK activation required for proper hyperosmotic response.

Authors:  Takeshi Maruyama; Hisae Kadowaki; Noriaki Okamoto; Atsushi Nagai; Isao Naguro; Atsushi Matsuzawa; Hiroshi Shibuya; Keiji Tanaka; Shigeo Murata; Kohsuke Takeda; Hideki Nishitoh; Hidenori Ichijo
Journal:  EMBO J       Date:  2010-06-29       Impact factor: 11.598

8.  Identification of ponatinib and other known kinase inhibitors with potent MEKK2 inhibitory activity.

Authors:  Syed Ahmad; Gary L Johnson; John E Scott
Journal:  Biochem Biophys Res Commun       Date:  2015-06-06       Impact factor: 3.575

9.  Kir2.1 Interaction with Stk38 Promotes Invasion and Metastasis of Human Gastric Cancer by Enhancing MEKK2-MEK1/2-ERK1/2 Signaling.

Authors:  Cheng-Dong Ji; Yan-Xia Wang; Dong-Fang Xiang; Qiang Liu; Zhi-Hua Zhou; Feng Qian; Lang Yang; Yong Ren; Wei Cui; Sen-Lin Xu; Xi-Long Zhao; Xia Zhang; Yan Wang; Peng Zhang; Ji-Ming Wang; You-Hong Cui; Xiu-Wu Bian
Journal:  Cancer Res       Date:  2018-03-16       Impact factor: 12.701

10.  MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.

Authors:  R Dale Brown; S Kelly Ambler; Min Li; Timothy M Sullivan; Lauren N Henry; Joseph T Crossno; Carlin S Long; Timothy P Garrington; Kurt R Stenmark
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-02       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.